AIM

AIM IMMUNOTECH INC COM NEW

AIM·00901B303·US·Common Stock·Healthcare - Biotechnology-13D/G

AIM (AIM IMMUNOTECH INC COM NEW) is held by 11 institutional investors as of Q2 2026. Largest holders: JANE STREET GROUP, LLC ($229,439), MORGAN STANLEY ($14,445), GEODE CAPITAL MANAGEMENT, LLC ($13,064). Net institutional sentiment: Mixed.

11
Holders
$285,599
Total Value
64% (11)
Consensus
7 buying - 4 selling
13F: Insider & Congress: Updated regularly
AIM

Smart Money Verdict

View all
Loading verdict
Held by 11 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 16, 2025 · Activists May 27, 2026 · Congress none

ActivistMPMitchell P. Kopin0.0%May 27, 2026
ActivistOAOrca Capital AG9.9%May 12, 2026
InsiderEKEquels Thomas KBuy $823.58Jun 13, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
807,885(+3929.9%)$229,4390.0%-13.91%
25
Increased
50,864(+5787.0%)$14,4450.0%-38.99%
20
Increased
46,003(+53.8%)$13,0640.0%-80.10%
17
New
32,444$9,2140.0%-10.71%
26
Increased
28,931(+28.9Kx)$8,2160.0%-10.78%
18
New
21,859$6,2080.0%-10.71%
24
Unchanged
17,519$4,9750.0%-64.29%
0
Increased
124,269(+144.2%)$350.0%-44.69%
18
Unchanged
15$30.0%-96.23%
0
Exited
0(-100.0%)$12,0450.0%-60.00%
0
Exited
0(-100.0%)$2,9250.0%-60.00%
0
Exited
0(-100.0%)$15,0000.0%-60.00%
0
Decreased
0(-100.0%)$00.0%-97.10%
0
Unchanged
1$00.0%-97.10%
0
AIMAIMAIM IMMUNOTECH INC COM NEW

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used